{"id":"fludeoxyglucose-pet-ct","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Fludeoxyglucose (18F-FDG) is a glucose analog that is taken up by cells with high metabolic rates, such as cancer cells. It is then detected by PET imaging, allowing for visualization of cancerous tissues.","oneSentence":"A positron-emitting glucose analog that accumulates in cancer cells, allowing for PET imaging.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:54:58.252Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer diagnosis and staging"}]},"trialDetails":[{"nctId":"NCT04929028","phase":"PHASE2","title":"Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-09","conditions":"AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma","enrollment":40},{"nctId":"NCT04665739","phase":"PHASE2","title":"Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-02-03","conditions":"Advanced Lung Neuroendocrine Tumor, Functioning Lung Neuroendocrine Tumor, Locally Advanced Lung Neuroendocrine Neoplasm","enrollment":70},{"nctId":"NCT03811015","phase":"PHASE3","title":"Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-16","conditions":"Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":636},{"nctId":"NCT01038778","phase":"PHASE1, PHASE2","title":"Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-10-29","conditions":"Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7","enrollment":47},{"nctId":"NCT07463807","phase":"PHASE1, PHASE2","title":"Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-06-26","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":162},{"nctId":"NCT05886036","phase":"PHASE2","title":"Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-01-23","conditions":"Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma","enrollment":70},{"nctId":"NCT04533750","phase":"PHASE1","title":"Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-12-20","conditions":"Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma","enrollment":21},{"nctId":"NCT03952585","phase":"PHASE2, PHASE3","title":"De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-09","conditions":"Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":384},{"nctId":"NCT05675410","phase":"PHASE3","title":"A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-11","conditions":"Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8","enrollment":1875},{"nctId":"NCT04214262","phase":"PHASE3","title":"Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-08-13","conditions":"Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":480},{"nctId":"NCT05286801","phase":"PHASE1, PHASE2","title":"Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-11-17","conditions":"Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma","enrollment":86},{"nctId":"NCT04316117","phase":"PHASE2","title":"Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2020-09-15","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma","enrollment":138},{"nctId":"NCT04166318","phase":"PHASE2","title":"Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2020-01-02","conditions":"Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma","enrollment":252},{"nctId":"NCT04119024","phase":"PHASE1","title":"Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Anusha Kalbasi","startDate":"2025-10-07","conditions":"Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8","enrollment":18},{"nctId":"NCT04020978","phase":"NA","title":"Parametric PET of Genitourinary Cancer","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2019-07-16","conditions":"Genitourinary Cancer","enrollment":11},{"nctId":"NCT05976763","phase":"PHASE3","title":"Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2023-10-20","conditions":"Mantle Cell Lymphoma","enrollment":421},{"nctId":"NCT03789240","phase":"PHASE2","title":"Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-22","conditions":"Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL","enrollment":33},{"nctId":"NCT06502691","phase":"PHASE1, PHASE2","title":"[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer","status":"RECRUITING","sponsor":"University of Washington","startDate":"2026-02-26","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma","enrollment":22},{"nctId":"NCT05710328","phase":"PHASE2","title":"Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2023-05-10","conditions":"Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma","enrollment":235},{"nctId":"NCT06179303","phase":"PHASE2","title":"Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer","status":"RECRUITING","sponsor":"University of Washington","startDate":"2024-07-22","conditions":"Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable HER2-Negative Breast Carcinoma","enrollment":60},{"nctId":"NCT04293562","phase":"PHASE3","title":"A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-07-21","conditions":"Acute Myeloid Leukemia","enrollment":1186},{"nctId":"NCT06820957","phase":"PHASE2, PHASE3","title":"Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-11-10","conditions":"CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma, Metastatic High Grade Sarcoma","enrollment":437},{"nctId":"NCT02226276","phase":"NA","title":"Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2015-01-07","conditions":"Bone Metastases, HER2-positive Breast Cancer, Liver Metastases","enrollment":10},{"nctId":"NCT05775939","phase":"NA","title":"PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2023-01-20","conditions":"Lung Carcinoma, Esophageal Carcinoma","enrollment":20},{"nctId":"NCT06500065","phase":"NA","title":"68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2024-09-30","conditions":"Soft Tissue Sarcoma","enrollment":30},{"nctId":"NCT06145633","phase":"PHASE2","title":"Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-09-18","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":15},{"nctId":"NCT04692103","phase":"PHASE2","title":"Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2021-07-10","conditions":"Estrogen Receptor Positive, Primary or Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7","enrollment":2},{"nctId":"NCT06842615","phase":"NA","title":"Prospective Evaluation of Diagnostic Performance of PanTum Detect Test in Adult Patients With Suspected or Confirmed Macroscopic Solid Pre-malignant or Malignant Lesion(s) Referred to Fludeoxyglucose (18F) PET/CT and in Adult Healthy Population","status":"RECRUITING","sponsor":"Comenius University","startDate":"2025-05-25","conditions":"Pre-malignant, Malignant","enrollment":134},{"nctId":"NCT07097363","phase":"PHASE2","title":"Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-12-07","conditions":"B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified","enrollment":18},{"nctId":"NCT04333537","phase":"PHASE2, PHASE3","title":"Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2020-09-23","conditions":"Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma","enrollment":686},{"nctId":"NCT07293247","phase":"PHASE2","title":"A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment","status":"NOT_YET_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2026-03-14","conditions":"Lung Non-Small Cell Carcinoma","enrollment":164},{"nctId":"NCT05455697","phase":"PHASE1, PHASE2","title":"Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma","status":"RECRUITING","sponsor":"University of Washington","startDate":"2023-01-26","conditions":"Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma","enrollment":35},{"nctId":"NCT02902757","phase":"NA","title":"FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2015-08-25","conditions":"Glioblastoma","enrollment":7},{"nctId":"NCT07278856","phase":"PHASE1","title":"Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas","status":"NOT_YET_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-04-27","conditions":"Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, Follicular Helper T-Cell Lymphoma, Follicular-Type","enrollment":20},{"nctId":"NCT05844306","phase":"NA","title":"RefleXion PET/CT Imaging Performance in Patients With Various Malignancies","status":"SUSPENDED","sponsor":"City of Hope Medical Center","startDate":"2023-03-15","conditions":"Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm","enrollment":20},{"nctId":"NCT02595879","phase":"PHASE1","title":"Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-09-18","conditions":"Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma","enrollment":21},{"nctId":"NCT05892393","phase":"PHASE1","title":"Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma","status":"RECRUITING","sponsor":"Robert Flavell, MD, PhD","startDate":"2023-06-16","conditions":"Multiple Myeloma, Plasma Cell Myeloma","enrollment":20},{"nctId":"NCT02390635","phase":"PHASE1","title":"PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-15","conditions":"Acute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARA","enrollment":77},{"nctId":"NCT06914999","phase":"EARLY_PHASE1","title":"Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-12-03","conditions":"Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":20},{"nctId":"NCT03604315","phase":"PHASE1","title":"Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-12-18","conditions":"Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma","enrollment":300},{"nctId":"NCT06171659","phase":"","title":"FDG PET/MR Imaging of Peripheral Pain Generators","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-11-19","conditions":"Pain, Nociceptive Pain","enrollment":128},{"nctId":"NCT05009979","phase":"PHASE2","title":"18F-DCFPyL PET/CT in Hepatocellular Carcinoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2023-01-18","conditions":"Hepatocellular Carcinoma","enrollment":8},{"nctId":"NCT07118176","phase":"PHASE1","title":"Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2025-08-01","conditions":"Anal Carcinoma, Bladder Carcinoma, Breast Carcinoma","enrollment":30},{"nctId":"NCT03432741","phase":"PHASE1","title":"Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2018-03-27","conditions":"Breast Adenocarcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma","enrollment":17},{"nctId":"NCT03824535","phase":"PHASE2","title":"18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules","status":"COMPLETED","sponsor":"Andrei Iagaru","startDate":"2019-02-04","conditions":"Cigarette Smoker, Current Smoker, Former Smoker","enrollment":15},{"nctId":"NCT05501665","phase":"PHASE1, PHASE2","title":"Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer","status":"RECRUITING","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2023-05-09","conditions":"Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage III Lung Cancer","enrollment":25},{"nctId":"NCT06626932","phase":"","title":"Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions","status":"NOT_YET_RECRUITING","sponsor":"mahenoor alaa eldeen naem","startDate":"2024-10","conditions":"Oncologic Diseases","enrollment":259},{"nctId":"NCT02773238","phase":"PHASE2","title":"FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05-20","conditions":"Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell Cancer AJCC v7","enrollment":51},{"nctId":"NCT04933617","phase":"PHASE1","title":"Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2022-03-24","conditions":"Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma","enrollment":8},{"nctId":"NCT03575949","phase":"NA","title":"Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-06-15","conditions":"Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Neoplasm in the Spine","enrollment":14},{"nctId":"NCT00678327","phase":"PHASE3","title":"Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma","status":"COMPLETED","sponsor":"University College, London","startDate":"2008-08-29","conditions":"Lymphoma","enrollment":1202},{"nctId":"NCT05950113","phase":"PHASE1","title":"CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-03-28","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":""},{"nctId":"NCT06362148","phase":"","title":"Circulating Tumor DNA in Peripheral T-cell Lymphomas","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-03-01","conditions":"Peripheral T-cell Lymphoma, NK/T-Cell Lymphoma","enrollment":50},{"nctId":"NCT04140513","phase":"NA","title":"Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer","status":"WITHDRAWN","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2020-10-09","conditions":"Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Advanced Oropharyngeal Squamous Cell Carcinoma","enrollment":""},{"nctId":"NCT00375830","phase":"PHASE2","title":"Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-01","conditions":"Cancer","enrollment":114},{"nctId":"NCT00794339","phase":"PHASE2","title":"Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer","status":"TERMINATED","sponsor":"American College of Radiology","startDate":"2009-07-29","conditions":"Cervical Cancer","enrollment":73},{"nctId":"NCT01390584","phase":"PHASE2","title":"Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma","status":"TERMINATED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2013-05-24","conditions":"Lymphoma","enrollment":6},{"nctId":"NCT01992861","phase":"","title":"MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer","status":"TERMINATED","sponsor":"University of Washington","startDate":"2014-02-14","conditions":"Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified","enrollment":51},{"nctId":"NCT03226249","phase":"PHASE2","title":"PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma","status":"UNKNOWN","sponsor":"Northwestern University","startDate":"2017-11-09","conditions":"Classical Hodgkin Lymphoma, Lymphocyte-Depleted Classical Hodgkin Lymphoma, Lymphocyte-Rich Classical Hodgkin Lymphoma","enrollment":30},{"nctId":"NCT02607423","phase":"PHASE2","title":"Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery","status":"WITHDRAWN","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2015-11-19","conditions":"Stage IIIA Non-Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT05062395","phase":"","title":"Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-03-30","conditions":"Myocarditis Acute","enrollment":13},{"nctId":"NCT00346125","phase":"NA","title":"PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2006-04-10","conditions":"Sarcoma","enrollment":70},{"nctId":"NCT02405078","phase":"EARLY_PHASE1","title":"Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-10-13","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma","enrollment":35},{"nctId":"NCT00822120","phase":"PHASE2","title":"S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2009-07","conditions":"Lymphoma, Nonneoplastic Condition","enrollment":371},{"nctId":"NCT02885272","phase":"EARLY_PHASE1","title":"FDG PET Imaging in Diagnosing Patients With Glioblastoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-10-28","conditions":"Brain Glioblastoma","enrollment":21},{"nctId":"NCT04080271","phase":"","title":"Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-11-01","conditions":"Bone Metastases","enrollment":66},{"nctId":"NCT00373711","phase":"","title":"Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2007-05","conditions":"Thyroid Cancer","enrollment":""},{"nctId":"NCT04266470","phase":"NA","title":"Monitoring Blood Flow and Metabolic Activity in Malignant Tissue of Head and Neck Region","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2020-03-09","conditions":"Squamous Cell Carcinoma of Head and Neck","enrollment":""},{"nctId":"NCT03937583","phase":"PHASE4","title":"Screening for Cancer in Patients With Unprovoked VTE","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2019-10-23","conditions":"Venous Thromboembolic Disease, Respiratory Disease, Pulmonary Disease","enrollment":650},{"nctId":"NCT02937168","phase":"PHASE4","title":"An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2017-05-08","conditions":"Asthma","enrollment":5},{"nctId":"NCT03231397","phase":"PHASE4","title":"Predictors of AAA Expansion and/or Rupture","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2017-08-01","conditions":"Abdominal Aortic Aneurysm (AAA)","enrollment":2},{"nctId":"NCT02149173","phase":"NA","title":"F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy","status":"TERMINATED","sponsor":"University of Washington","startDate":"2010-09-15","conditions":"Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7","enrollment":29},{"nctId":"NCT00978874","phase":"NA","title":"Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer","status":"TERMINATED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2008-05","conditions":"Cervical Cancer","enrollment":15},{"nctId":"NCT01132807","phase":"PHASE2","title":"Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-05","conditions":"Lymphoma","enrollment":164},{"nctId":"NCT01004718","phase":"NA","title":"Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2009-05","conditions":"Lymphoma","enrollment":10},{"nctId":"NCT01807117","phase":"NA","title":"PET-MRI in Diagnosing Patients With Colon or Rectal Cancer","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2013-04","conditions":"Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIA Colon Cancer","enrollment":15},{"nctId":"NCT01507428","phase":"PHASE2","title":"Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer","status":"UNKNOWN","sponsor":"National Cancer Institute (NCI)","startDate":"2012-02-22","conditions":"Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell Cancer AJCC v7","enrollment":138},{"nctId":"NCT03262389","phase":"PHASE2","title":"Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma","status":"COMPLETED","sponsor":"Michael C Roarke, MD","startDate":"2017-09-19","conditions":"Multiple Myeloma","enrollment":10},{"nctId":"NCT00983697","phase":"NA","title":"FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer","status":"UNKNOWN","sponsor":"American College of Radiology Imaging Network","startDate":"2010-04-01","conditions":"Head and Neck Cancer","enrollment":292},{"nctId":"NCT01341730","phase":"PHASE4","title":"The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)","status":"TERMINATED","sponsor":"The Catholic University of Korea","startDate":"2011-06","conditions":"Atherosclerosis, Coronary Artery Disease","enrollment":41},{"nctId":"NCT00450567","phase":"","title":"Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2004-12","conditions":"Lung Cancer","enrollment":36},{"nctId":"NCT02919332","phase":"","title":"Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2016-06-08","conditions":"Glioblastoma, Glioma","enrollment":""},{"nctId":"NCT04315584","phase":"EARLY_PHASE1","title":"FDG and FDOPA PET Demonstration of Functional Brain Abnormalities","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2020-03-15","conditions":"Glioblastoma","enrollment":5},{"nctId":"NCT02287636","phase":"NA","title":"PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2013-04","conditions":"Childhood Cancer","enrollment":13},{"nctId":"NCT00602043","phase":"PHASE2","title":"F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-09","conditions":"Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer","enrollment":20},{"nctId":"NCT00553150","phase":"PHASE1, PHASE2","title":"Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2009-03","conditions":"Brain and Central Nervous System Tumors","enrollment":122},{"nctId":"NCT01806675","phase":"PHASE1, PHASE2","title":"18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy","status":"COMPLETED","sponsor":"Sanjiv Sam Gambhir","startDate":"2013-03-04","conditions":"Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma","enrollment":25},{"nctId":"NCT00416455","phase":"PHASE1, PHASE2","title":"Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-09","conditions":"Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma","enrollment":384},{"nctId":"NCT02891616","phase":"PHASE1","title":"18F-FLT PET Imaging in Patients With Advanced Melanoma","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2016-10-10","conditions":"Melanoma","enrollment":4},{"nctId":"NCT02717572","phase":"PHASE1","title":"18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2016-03-01","conditions":"Solid Tumor, Adult","enrollment":19},{"nctId":"NCT00424138","phase":"NA","title":"FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy","status":"TERMINATED","sponsor":"American College of Radiology Imaging Network","startDate":"2007-03-30","conditions":"Lung Cancer","enrollment":96},{"nctId":"NCT01561014","phase":"PHASE1","title":"Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2007-04","conditions":"Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach","enrollment":9},{"nctId":"NCT01789892","phase":"NA","title":"Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer","status":"WITHDRAWN","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2011-06","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT01146054","phase":"PHASE2","title":"Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-10","conditions":"Pancreatic Cancer","enrollment":59},{"nctId":"NCT01169350","phase":"PHASE2","title":"18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-02","conditions":"Recurrent Adult Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma","enrollment":8},{"nctId":"NCT00941070","phase":"PHASE2","title":"Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-07","conditions":"Recurrent Cervical Cancer, Recurrent Vaginal Cancer, Stage IB Cervical Cancer","enrollment":26},{"nctId":"NCT00062374","phase":"PHASE2","title":"Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2003-06","conditions":"Gastric Adenocarcinoma, Stage II Gastric Cancer, Stage III Gastric Cancer","enrollment":55},{"nctId":"NCT00537056","phase":"NA","title":"Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI","status":"COMPLETED","sponsor":"Stanford University","startDate":"2007-10","conditions":"Kidney Neoplasms, Carcinoma, Renal Cell, Kidney (Renal Cell) Cancer","enrollment":17},{"nctId":"NCT00958321","phase":"PHASE2","title":"Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35","status":"TERMINATED","sponsor":"Cancer Trials Ireland","startDate":"2007-03","conditions":"Lung Cancer, Metastatic Cancer","enrollment":40},{"nctId":"NCT02811185","phase":"PHASE4","title":"Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2016-06","conditions":"Positron-Emission Tomography and Cone-Beam Computed Tomography","enrollment":1012}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["F-18 FDG PET CT"],"phase":"phase_2","status":"active","brandName":"Fludeoxyglucose PET CT","genericName":"Fludeoxyglucose PET CT","companyName":"Michael C Roarke, MD","companyId":"michael-c-roarke-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A positron-emitting glucose analog that accumulates in cancer cells, allowing for PET imaging. Used for Cancer diagnosis and staging.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}